Contents
Download PDF
pdf Download XML
180 Views
56 Downloads
Share this article
Short Communication | Volume 1 Issue 2 (July-Dec, 2020) | Pages 1 - 2
Unveiling the Mystery of Spate of COVID-19 Reinfections
 ,
1
Senior Resident, Department of Biochemistry, VMMC and SJH, New Delhi, India
2
Director, Professor and HOD, Department of Biochemistry, VMMC and SJH, New Delhi, India
Under a Creative Commons license
Open Access
Received
Oct. 10, 2020
Revised
Nov. 16, 2020
Accepted
Dec. 4, 2020
Published
Dec. 15, 2020
Abstract

The thought of contracting COVID-19 infection is unsavory in itself. Now, Health care units are noting increasing number of cases of suspected reinfections. All such cases have one unique episodic feature; second episode of infection being more severe than the first one. Although, reinfection within six months of first episode of COVID-19 infection is rare due to protective immunity. But in recent times, a mysterious spate of COVID-19 reinfections has been reported. The mystery revolves around many pillars like inadequate immune response (the first time), waning immunity, or mutant strain infection. So, these contribute to the key factors responsible for the etiology of possible COVID-19 reinfections worldwide. 

Keywords
SHORT COMMUNICATION

The thought of contracting COVID-19 infection is unsavory in itself. Now, Health care units are noting increasing number of cases of suspected reinfections. All such cases have one unique episodic feature, second episode of infection being more severe than the first one.

 

The key features of severity of COVID-19 reinfection are oxygen dependency, new symptomatology with radiological worsening, breathlessness, cough, fever, body myalgia etc. There is an immediate need of genome sequencing to confirm such reinfection cases.

 

Although, reinfection within six months of first episode of COVID-19 infection is rare due to protective immunity. But in recent times, a mysterious spate of COVID-19 reinfections has been reported [1]. The mystery revolves around many pillars like inadequate immune response (the first time), waning immunity, or mutant strain infection. So, these contribute to the key factors responsible for the etiology of possible COVID-19 reinfections worldwide.

 

Firstly, there is a possibility of inadequate immune response during the first episode of COVID-19 infection [2], resulting in bounce back of reinfection with severe symptoms like breathlessness, cough, fever, lung involvement often seen on CT scans.

 

Secondly, there is a chance of waning immunity, which imparts the progression to the COVID-19 reinfection [3].

 

Thirdly, there is also possibility of mutant strain infection. In the Sars-CoV-2 virus or COVID-19, reinfections happen when a mutated version of the same virus successfully evades the immune system. According to the recent study by Professor Vinod Scaria, a pioneer in Precision Medicine and Clinical, Genomics at the Institute of Genomics and Integrative Biology (IGIB) New Delhi, some 80 such genetic mutations have already been found in research lab settings worldwide. 

 

In addition to this, there are other major factors like lack of genomic confirmation, underreporting, financial constraints owing to the expensive genomic sampling, CT scans, COVID suspected ICU Settings etc.

 

All in all, there is an immediate need to look for the long-term effects of COVID-19 to decode the mystery of Spate of COVID-19 reinfections.

REFERENCE
  1. To, K.K.W., et al. “COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing.” Clinical Infectious Diseases, August 2020, https://doi.org/10.1093/cid/ciaa1275.

  2. Long, Q.X., et al. “Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.” Nature Medicine, vol. 26, no. 8, 2020, pp. 1200–1204.

  3. Malfertheiner, S.F., et al. “Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: a prospective longitudinal study.” Journal of Clinical Virology, vol. 130, 2020, article 104575.

Recommended Articles
Research Article
It Remains Unproven That the Variant M.8231C>A Causes Coronary Atherosclerosis
Published: 15/07/2020
Download PDF
Research Article
Vision for a Brighter Kangra: Unmasking the Truth about Pink Eye – A Comprehensive Study on Types, Symptoms, and Proactive Prevention in Himachal Pradesh’s Kangra District
...
Published: 11/11/2023
Download PDF
Research Article
Leigh Syndrome Should Not Be Diagnosed Exclusively Upon Cerebral MRI
Published: 15/07/2020
Download PDF
Research Article
Release Kinetic Study of Matrix Type Transdermal Patch Using an Analgesic Drug
...
Published: 10/08/2020
Download PDF
Chat on WhatsApp
Flowbite Logo
PO Box 101, Nakuru
Kenya.
Email: office@iarconsortium.org

Editorial Office:
J.L Bhavan, Near Radison Blu Hotel,
Jalukbari, Guwahati-India
Useful Links
Order Hard Copy
Privacy policy
Terms and Conditions
Refund Policy
Shipping Policy
Others
About Us
Team Members
Contact Us
Online Payments
Join as Editor
Join as Reviewer
Subscribe to our Newsletter
+91 60029-93949
Follow us
MOST SEARCHED KEYWORDS
Copyright © iARCON International LLP . All Rights Reserved.